We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparative Analytical Performance of Various HbA1c Assays in Iran.
- Authors
Razi, Farideh; Farzami, Marjan Rahnamaye; Ebrahimi, Soltan Ahmad; Nahid, Mehrzad; Bigdeli, Mostafa Gholi; Sheidaei, Ali; Ghasemian, Anoosheh; Tootee, Ali; Keramati, Tahereh; Esfahani, Ensieh Nasli; Larijani, Bagher; Pasalar, Parvin
- Abstract
Introduction: Hemoglobin A1 c (HbA1c) measurement devices are widely used to evaluate glycemic control in diabetic patients. The aim of this study was to investigate the comparability of various HbA1c instruments used in Iran. Methods: In the present study, 154 fresh whole blood samples from diabetic patients, with different HbA1c levels (4.0%-10%) and no types of hemoglobinopathy were analyzed by six HbA1c assays including one high performance liquid chromatography (HPLC) method (D10 HbA1c), two immunoassay methods (COBAS INTEGRA400 and ParsAzmoon kit), one Boronate affinity method (Nycocard Reader II), and two ion exchange methods (Biosystems and DS5). The two National Glycohemoglobin Standardization Programs (NGSP) certified system, D10 and COBAS INTEGRA 400 which are certified as secondary reference measurement procedures, were considered as reference methods. The CLSI document (EP9-A2) - Method comparison and Bias estimation using patient samples, approved guideline - was used to compare the performance of different HbA1c instruments. Results: The mean of HbA1c in all four types of assays was less than the reference methods (P-value < 0.01).The mean of absolute difference between the reference methods was the least (0.11 %). Among the other four tests, Biosystems had the smallest mean of difference (-0.21 %), while ParsAzmoon had the highest (-1.18%). ParsAzmoon showed the greatest difference (95% confidence interval) when compared to D10 [-15.5%(-5.7%to -25.3%)] and COBAS INTEGRA [-17% (-9.16% to -24.84%)]. The highest regression slope (B) was found in DS5 method (0.96) in regression model with both reference methods. Conclusion: It can be concluded that although HbA1 c standardization programs have resulted in great improvements in the comparability of HbA1 c assays, unacceptable errors still exist and further national and international projects are required for standardization of HbA1 c measurement. In this situation, it is recommended to use the same laboratory for HbA1 c measurement to monitor diabetic patients.
- Subjects
DIAGNOSIS of diabetes; BLOOD sugar monitors; COMPARATIVE studies; GLYCOSYLATED hemoglobin; HIGH performance liquid chromatography; REGRESSION analysis
- Publication
Archives of Iranian Medicine (AIM), 2016, Vol 19, Issue 6, p414
- ISSN
1029-2977
- Publication type
Article